Zenithpharma

zenithpharma.ma

Born of the complicity of its partners, our laboratory defines itself as a young, innovative and bold laboratory: A Moroccan laboratory that meets international standards and standards. • Young: - By its creation in 2005 - By its managerial staff • Innovative: - By the quality of its products - By its development strategy and the quality of its services • Bold: - Through its decentralization policy by choosing to establish itself in the South of the Kingdom.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

LABCORP PLANS LABORATORY EXPANSION IN JAPAN THROUGH BML COLLABORATION

Labcorp | July 04, 2022

news image

Labcorp a leading global life sciences company, announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services. Extending their strategic relationship that dates back more than a decade, Labcorp Drug Development and BML will begin work on a new laboratory fa...

Read More

Business Insights

ANOKION ANNOUNCES $35 MILLION EQUITY INVESTMENT FROM PFIZER

Anokion | October 19, 2022

news image

Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance announced that Pfizer has made a $35 million equity investment in Anokion through the Pfizer Breakthrough Growth Initiative. In conjunction with the investment, Michael Vincent, M.D., Ph.D., senior vice president and chief scientific officer, Inflammation & Immunology, Pfizer, has joined the company’s scientific advisory board, which will be announced later thi...

Read More

Business Insights

PROTECT PHARMACEUTICAL CORPORATION HAS ACQUIRED TOP NOTCH SOFTWARE DEVELOPMENT COMPANY.

PROTECT PHARMACEUTICAL Corp | June 28, 2022

news image

Protect Pharmaceutical Corporation has acquired the 100% of the shares of CJSC “Inaiapp”, a Belarusian developer of corporate software for business digitalization. With 8 years of blockchain development experience and list of long term clients, Inaiapp will bring its qualification and management processes to a new level. “Robotic process automation, AI systems and machine learning systems, blockchain-based solutions, Data Scie...

Read More

NO SINGLE MANUFACTURER CAN MEET CORONAVIRUS VACCINE GLOBAL DEMAND, SAYS MODERNA CEO

Cnbc | May 13, 2020

news image

Moderna CEO Stephane Bancel said Tuesday that he hopes many coronavirus vaccines from multiple manufacturers will be approved to enter the market, because no single manufacturer can meet global demand. Regeneron CEO Leonard Schleifer, whose company is devel...

Read More
news image

Business Insights

LABCORP PLANS LABORATORY EXPANSION IN JAPAN THROUGH BML COLLABORATION

Labcorp | July 04, 2022

Labcorp a leading global life sciences company, announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services. Extending their strategic relationship that dates back more than a decade, Labcorp Drug Development and BML will begin work on a new laboratory fa...

Read More
news image

Business Insights

ANOKION ANNOUNCES $35 MILLION EQUITY INVESTMENT FROM PFIZER

Anokion | October 19, 2022

Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance announced that Pfizer has made a $35 million equity investment in Anokion through the Pfizer Breakthrough Growth Initiative. In conjunction with the investment, Michael Vincent, M.D., Ph.D., senior vice president and chief scientific officer, Inflammation & Immunology, Pfizer, has joined the company’s scientific advisory board, which will be announced later thi...

Read More
news image

Business Insights

PROTECT PHARMACEUTICAL CORPORATION HAS ACQUIRED TOP NOTCH SOFTWARE DEVELOPMENT COMPANY.

PROTECT PHARMACEUTICAL Corp | June 28, 2022

Protect Pharmaceutical Corporation has acquired the 100% of the shares of CJSC “Inaiapp”, a Belarusian developer of corporate software for business digitalization. With 8 years of blockchain development experience and list of long term clients, Inaiapp will bring its qualification and management processes to a new level. “Robotic process automation, AI systems and machine learning systems, blockchain-based solutions, Data Scie...

Read More
news image

NO SINGLE MANUFACTURER CAN MEET CORONAVIRUS VACCINE GLOBAL DEMAND, SAYS MODERNA CEO

Cnbc | May 13, 2020

Moderna CEO Stephane Bancel said Tuesday that he hopes many coronavirus vaccines from multiple manufacturers will be approved to enter the market, because no single manufacturer can meet global demand. Regeneron CEO Leonard Schleifer, whose company is devel...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us